tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresíva - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
rocuronium bromide hameln 10 mg/ml injekčný/infúzny roztok
hameln pharma gmbh, nemecko - rokuróniumbromid - 63 - myorelaxantia
azzavix 500 mg gastrorezistentné tablety
faes farma, s.a., Španielsko - mesalazín - 29 - antirheumatica, antiphlogistica, antiuratica
azzavix 1000 mg gastrorezistentné tablety
faes farma, s.a., Španielsko - mesalazín - 29 - antirheumatica, antiphlogistica, antiuratica
allopurinol medreg 300 mg
medreg s.r.o., Česká republika - alopurinol - 29 - antirheumatica, antiphlogistica, antiuratica
suxamethonium chlorid vuab 100 mg
vuab pharma a.s., Česká republika - suxametónium - 63 - myorelaxantia
suxamethonium chlorid vuab 250 mg
vuab pharma a.s., Česká republika - suxametónium - 63 - myorelaxantia
nplate
amgen europe b.v. - romiplostim - purpura, trombocytopenická, idiopatická - antihemoragiká - adults:nplate is indicated for the treatment of primary immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidy, imunoglobulíny). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. kortikosteroidy, imunoglobulíny).
salofalk 250 čapíky
dr. falk pharma gmbh, nemecko - mesalazín - 73 - spasmolytica
salofalk 4 g/60 g klysmen
dr. falk pharma gmbh, nemecko - mesalazín - 29 - antirheumatica, antiphlogistica, antiuratica